✅ Day 2 at #ACC25 in the books! Thank you to everyone who stopped by our Meet & Greet to connect with our leadership and learn how Cleerly is transforming cardiac care with AI-powered, non-invasive tools for diagnosing and managing coronary artery disease. Our CEO & Founder, Dr. James Min, MD, joined a 'Cross-Industry Panel Discussion on Community Education, Cardiovascular Disease Prevention, and Screening Programs. In a Lounge & Learn session, our VP of Medical Affairs, Michelle Gearhart, spoke on 'Increasing Female Physician Leadership in Clinical Trials. We're proud to be part of these vital discussions. 👏❤️ But we’re not done yet! There’s still plenty of heart talk ahead. 💙 Come visit us at booth 16033. We’d love to chat about how we can work together to create a world without heart attacks. 🗓️ Full schedule here: https://lnkd.in/gtdjSHwr #ACC25 #YesCCT #CTFirst #HealthcareInnovation
-
-
-
-
-
+2
well done team Cleerly!! yuo guys are rocking it at American College of Cardiology
PATH2 | CoFounder
3dI spy Jim Hartman!